Benazepril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor widely prescribed for the treatment of hypertension, congestive heart failure, and myocardial infarction. As a prodrug, it undergoes… Read more
Benazepril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor widely prescribed for the treatment of hypertension, congestive heart failure, and myocardial infarction. As a prodrug, it undergoes hepatic metabolism to release the active metabolite, benazeprilat, which effectively lowers blood pressure by inhibiting the ACE enzyme. This category contains a comprehensive range of high-quality reference standards, including the API, pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, analytical method validation, and routine quality control of the drug substance. By providing characterized standards, these compounds assist in identifying and quantifying specific impurities or metabolites during stability studies, ensuring compliance with regulatory requirements and supporting the overall safety and efficacy assessments of pharmaceutical formulations.
